These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26740330)
1. Tumoral NKG2D alters cell cycle of acute myeloid leukemic cells and reduces NK cell-mediated immune surveillance. Tang M; Acheampong DO; Wang Y; Xie W; Wang M; Zhang J Immunol Res; 2016 Jun; 64(3):754-64. PubMed ID: 26740330 [TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914 [TBL] [Abstract][Full Text] [Related]
3. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma. Belting L; Hömberg N; Przewoznik M; Brenner C; Riedel T; Flatley A; Polić B; Busch DH; Röcken M; Mocikat R Eur J Immunol; 2015 Sep; 45(9):2593-601. PubMed ID: 26151313 [TBL] [Abstract][Full Text] [Related]
4. Natural killer group 2D receptor and its ligands in cancer immune escape. Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924 [TBL] [Abstract][Full Text] [Related]
5. NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection. Wang Y; Wang W; Shen C; Wang Y; Jiao M; Yu W; Yin H; Shang X; Liang Q; Zhao C Sci Rep; 2017 Mar; 7(1):88. PubMed ID: 28273905 [TBL] [Abstract][Full Text] [Related]
6. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis. Guo SW; Du Y; Liu X Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956 [TBL] [Abstract][Full Text] [Related]
7. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
9. Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition. Di Modica M; Sfondrini L; Regondi V; Varchetta S; Oliviero B; Mariani G; Bianchi GV; Generali D; Balsari A; Triulzi T; Tagliabue E Oncotarget; 2016 Jan; 7(1):255-65. PubMed ID: 26595802 [TBL] [Abstract][Full Text] [Related]
10. Requirements for control of B-cell lymphoma by NK cells. Brenner CD; King S; Przewoznik M; Wolters I; Adam C; Bornkamm GW; Busch DH; Röcken M; Mocikat R Eur J Immunol; 2010 Feb; 40(2):494-504. PubMed ID: 19950185 [TBL] [Abstract][Full Text] [Related]
11. NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML. Schlegel P; Ditthard K; Lang P; Mezger M; Michaelis S; Handgretinger R; Pfeiffer M J Immunol Res; 2015; 2015():473175. PubMed ID: 26236752 [TBL] [Abstract][Full Text] [Related]
12. IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway. Song H; Park H; Kim J; Park G; Kim YS; Kim SM; Kim D; Seo SK; Lee HK; Cho D; Hur D Immunol Lett; 2011 May; 136(2):187-93. PubMed ID: 21277902 [TBL] [Abstract][Full Text] [Related]
13. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells. Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191 [TBL] [Abstract][Full Text] [Related]
17. Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia. Märklin M; Hagelstein I; Koerner SP; Rothfelder K; Pfluegler MS; Schumacher A; Grosse-Hovest L; Jung G; Salih HR J Immunother Cancer; 2019 May; 7(1):143. PubMed ID: 31142382 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway. Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340 [TBL] [Abstract][Full Text] [Related]
19. NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hou X; Zhou R; Wei H; Sun R; Tian Z Hepatology; 2009 Mar; 49(3):940-9. PubMed ID: 19177594 [TBL] [Abstract][Full Text] [Related]
20. Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions. Espinoza JL; Takami A; Yoshioka K; Nakata K; Sato T; Kasahara Y; Nakao S Haematologica; 2012 Sep; 97(9):1295-303. PubMed ID: 22491735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]